Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House approves bill letting manufacturers provide individualized investigational treatments; liability and consent provisions added
Summary
The House passed a bill allowing manufacturers to make individualized investigational drugs, biologics or devices available to eligible patients with life‑threatening or severely debilitating conditions, including provisions limiting provider discipline for recommendations and clarifying estate liability if a patient dies.
TOPEKA — The Kansas House passed legislation that would create a statutory framework allowing manufacturers to supply individualized investigational treatments to eligible patients with life‑threatening or severely debilitating illnesses.
Representative John Steens, the bill’s carrier, described the measure as a limited pathway for patients seeking individualized investigational products when no approved options exist. “This bill would authorize a manufacturer operating in an eligible facility to make available individualized investigative treatments for individuals with life‑threatening or severely…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
